PublizoomAward notice Supplies
Εκαπυ 3/2024 φαρμακα
Notice published in Greek. The AI analysis summarises it for you in your language.
- Public buyer
- Εθνική Κεντρική Αρχή Προμηθειών Υγείας (E.K.A.Π.Υ.)
Αθήνα - Place of performance
- ΑΘΗΝΑ
- Estimated value
- €94,054,662 excl. VAT
- Amount awarded
- €121,222 excl. VAT
- Planned end of contract
- 25 September 2029
likely re-tender around March 2029 - Bids received
- 1
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 23 October 2026
- Notice language
- Greek
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
ΕΚΑΠΥ 3/2024 ΦΑΡΜΑΚΑ
Awarded to
- MEDICUS A.E. ΑΝΩΝΥΜΗ ΒΙΟΜΗΧΑΝΙΚΗ – ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΕΙΔΩΝ
- ΑΝΦΑΡΜ ΕΛΛΑΣ Α.Ε.
- DEMO ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΩΝ
- ΦΑΡΜΑΖΑΚ ΑΝΩΝΥΜΗ ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΜΠΟΡΙΚΗ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ
- ΒΙΑΝΕΞ ΑΕ ΑΝΩΝΥΜΟΣ ΕΜΠΟΡΟΒΙΟΜΗΧΑΝΙΚΗ ΤΟΥΡΙΣΤΙΚΗ ΞΕΝΟΔΟΧΕΙΑΚΗ & ΝΑΥΤΙΛΙΑΚΗ ΑΝΩΝΥΜΟΣ ΕΤΑΙΡΕΙΑ
- ΚΟΠΕΡ ΦΑΡΜΑΚΟΒΙΟΜΗΧΑΝΙΑ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ
- VIATRIS HELLAS ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΥΝΗΣ
- VOCATE ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ
- ΒΙΟΣΕΡ ΑΕ ΒΙΟΜΗΧΑΝΙΑ ΠΑΡΕΝΤΕΡΙΚΩΝ ΔΙΑΛΥΜΑΤΩΝ
22 lots
- Α/Α 1 BUDESONIDE INH.SUS.N 0,25MG/ML
- Α/Α 2 BUDESONIDE INH.SUS.N 0,50MG/ML
- Α/Α 3 CALCIUM FOLINATE INJ.SO.INF & INJ.SOL 200MG/20ML VIAL
- Α/Α 4 CARBOPLATIN SOL.INF 450MG/VIAL
- Α/Α 5 CEFEPIME DIHYDROCHLORIDE MONOHYDRATE PD.I.S.INF & PS.INJ.SOL & PD.INJ.SOL 2G
- Α/Α 6 CEFTRIAXONE PD.I.S.INF & PS.INJ.SOL 1000MG
- Α/Α 7 ESOMEPRAZOLE SODIUM PD.I.S.INF 40MG/VIAL
- Α/Α 8 GEMCITABINE PD.SOL.INF & C/S.SOL.IN 1000MG
- Α/Α 9 GEMCITABINE PD.SOL.INF & C/S.SOL.IN 200MG
- Α/Α 10 IPRATROPIUM+SALBUTAMOL INH.SOL.N & INH.NE.SOL (0,5+2,5)MG/2,5ML
- Α/Α 11 IRINOTECAN C/S.SOL.IN 20MG/ML/15ML
- Α/Α 12 LINEZOLID SOL.INF & SOL.IV.INF 2MG/ML
- Α/Α 13 OMEPRAZOLE PS.INJ.SOL 40 MG/VIAL
- Α/Α 14 OMEPRAZOLE PD.SOL.INF 40 MG/VIAL
- Α/Α 15 PACLITAXEL C/S.SOL.IN 300MG/VIAL
- Α/Α 16 PIPERACILLIN+TAZOBACTAM PD.SOL.INF (2+0,250)GR/VIAL
- Α/Α 17 PIPERACILLIN+TAZOBACTAM PD.INJ.SOL & PD.SOL.INF (4+0,500)GR/VIAL
- Α/Α 18 TEICOPLANIN P.SV.INJ.F 200MG/VIAL
- Α/Α 19 TEICOPLANIN P.SV.INJ.F 400MG/VIAL
- Α/Α 21 CLINDAMYCIN PHOSPHATE INJ.SOL & INJ.SO.INF & SO.INJ.INF 600MG/4ML AMP
- Α/Α 24 PROPOFOL INJ.EM.IN 1% W/V 100ML
- Α/Α 25 PROPOFOL INJ.EM.IN 2% W/V 50ML
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €129,724
- Median
- €175,195
- A quarter above
- €278,460
Amounts awarded (excl. VAT) over the last 3 years for 37 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 735496-2026.